Publications in collaboration with researchers from Complexo Hospitalario Universitario de Vigo (83)

2024

  1. A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 79, Núm. 4, pp. 910-919

  2. A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 8, pp. 1794-1800

  3. Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study

    Clinical Microbiology and Infection, Vol. 30, Núm. 8, pp. 1035-1041

  4. Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 10, pp. 2011-2022

  5. Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study

    Annals of Clinical Microbiology and Antimicrobials, Vol. 23, Núm. 1

  6. Early Antibiotic De-escalation in Patients With Severe Infections Due to Bloodstream Infection by Enterobacterales: A Post Hoc Analysis of a Prospective Multicentre Cohort

    International Journal of Antimicrobial Agents, Vol. 64, Núm. 5

  7. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

  8. Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study

    The Lancet Microbe, Vol. 5, Núm. 4, pp. e390-e399

2023

  1. A Confounder in the Study of a Patient With Infective Endocarditis

    JACC: Case Reports, Vol. 28

  2. Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 4, pp. 238-242

  3. Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

    Annals of Clinical Microbiology and Antimicrobials, Vol. 22, Núm. 1

  4. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  5. Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value

    Respiratory Research, Vol. 24, Núm. 1

  6. Mycotic Aortic Aneurysm after Intravesical Bacillus Calmette-Guérin Instillation for Bladder Carcinoma

    Infectious Diseases in Clinical Practice

  7. Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study)

    International Journal of Antimicrobial Agents, Vol. 61, Núm. 3

2022

  1. Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 9, pp. 1173-1182

  2. Cerebrospinal fluid drainage-related ventriculitis due to multidrug-resistant microorganisms

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 6, pp. 322-325

  3. Gastrointestinal colonization by OXA-48-producing Enterobacterales: risk factors for persistent carriage

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 12, pp. 1399-1405

  4. Infección aguda por Citomegalovirus en pacientes inmunocompetentes: A propósito de _4_ casos diagnositcados en corto periodo de tiempo

    Galicia Clínica, Vol. 83, Núm. 2, pp. 67-68

  5. Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests

    Oral Diseases, Vol. 28, Núm. S1, pp. 908-911